The robotic surgery devices market size has grown rapidly in recent years. It will grow from $8.81 billion in 2025 to $10.19 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to expansion of minimally invasive surgical procedures, rising surgeon preference for robotic assistance, increasing hospital investments in advanced surgery systems, growth in complex surgical cases, improvements in robotic instrumentation.
The robotic surgery devices market size is expected to see rapid growth in the next few years. It will grow to $18.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing adoption of autonomous surgical functions, rising demand for precision surgery, expansion of robotic surgery training programs, growing integration of ai-assisted decision support, increasing outpatient robotic procedures. Major trends in the forecast period include increasing adoption of robot-assisted minimally invasive surgeries, rising demand for multi-specialty robotic platforms, growing use of advanced surgical visualization systems, expansion of remote and teleoperated surgery, enhanced focus on surgical precision and outcomes.
The growing preference for minimally invasive technology is expected to support the expansion of the robotic surgery devices market in the coming years. Minimally invasive technology involves surgical procedures performed through small incisions using advanced instruments and robotic systems, which help limit tissue trauma and shorten recovery periods. This increasing preference is driven by patient demand for quicker recovery, fewer post-operative complications, and reduced hospital stays. As a result, adoption of robotic-assisted platforms is accelerating, as these systems enhance surgical precision, enable complex interventions, and improve overall clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, minimally invasive procedures grew by 7 percent in 2023, exceeding the growth rate of surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid fillers surpassing 9 million and 5 million treatments, respectively. Consequently, the increasing demand for minimally invasive technology is contributing significantly to the growth of the robotic surgery devices market.
Leading companies operating in the robotic surgery devices market are increasingly emphasizing technological innovation, particularly through the development of advanced robotic surgery platforms, to improve procedural efficiency, surgical accuracy, and overall economic performance. These platforms are being engineered to minimize radiation exposure, enhance surgeon ergonomics, and support faster patient recovery through minimally invasive approaches. R-One+ is a robotic system designed for cardiac procedures. For example, in May 2023, Robocath, a France-based medical technology company, launched R-One+, a new robotic system for heart surgery. The R-One+ platform is designed to enhance treatment precision and safety, reduce radiation exposure, and improve the overall patient experience. By enabling interventional cardiologists to perform coronary angioplasty procedures using a tablet and joystick interface, this system represents a notable advancement in interventional cardiology, offering clinicians a tool to improve patient outcomes while lowering procedural risks.
In October 2025, Zimmer Biomet Holdings, Inc., a United States-based medical technology company, completed the acquisition of Monogram Technologies, Inc. for an undisclosed consideration. Through this transaction, Zimmer Biomet seeks to strengthen its position in the robotic surgery devices market by integrating Monogram’s semi-autonomous and fully autonomous robotic systems into its existing portfolio. This includes incorporating Monogram’s computed tomography-based, artificial intelligence-navigated total knee arthroplasty technology into Zimmer Biomet’s robotic and navigation platforms. Monogram Technologies develops surgeon-guided robotic technologies for orthopedic applications, with a particular focus on total knee arthroplasty, and the acquisition is expected to enhance Zimmer Biomet’s capabilities in autonomous orthopedic robotics.
Major companies operating in the robotic surgery devices market are Intuitive Surgical Inc., Stryker Corporation, Medtronic plc, Smith & Nephew plc, Johnson & Johnson, TransEnterix Inc., Zimmer Biomet Holdings Inc., Auris Health Inc., CMR Surgical Ltd., Verb Surgical Inc., Renishaw plc, Think Surgical Inc., Corindus Vascular Robotics Inc., Mazor Robotics Ltd., Titan Medical Inc., Virtual Incision Corporation, Medrobotics Corporation, Preceyes BV, Microbot Medical Inc., Asensus Surgical Inc., Avatera Medical GmbH, Medicaroid Corporation, Hansen Medical Inc., Edge Surgical Inc., Synaptive Medical, Aesculap Inc.
North America was the largest region in the robotic surgery devices market in 2025. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the robotic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the robotic surgery devices market by increasing costs of imported robotic arms, sensors, vision systems, electronic control units, and precision instruments. Hospitals in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces manufacturing and export cost pressures. These tariffs are increasing system acquisition costs and slowing new installations. However, they are also encouraging localized assembly, regional component sourcing, and innovation in modular robotic surgery systems.
The robotic surgery devices market research report is one of a series of new reports that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robotic surgery devices play a crucial role in enabling doctors to execute intricate minimally invasive procedures with precision and adaptability.
The primary offerings within the robotic surgery devices market include robotic systems, instruments and accessories, as well as services. The services, also known as robot-assisted surgery services, are delivered by the robotic systems. These devices find application in various surgical categories such as urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These advanced tools are utilized in both hospital settings and ambulatory surgery centers.
Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The robotic surgery devices market size is expected to see rapid growth in the next few years. It will grow to $18.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing adoption of autonomous surgical functions, rising demand for precision surgery, expansion of robotic surgery training programs, growing integration of ai-assisted decision support, increasing outpatient robotic procedures. Major trends in the forecast period include increasing adoption of robot-assisted minimally invasive surgeries, rising demand for multi-specialty robotic platforms, growing use of advanced surgical visualization systems, expansion of remote and teleoperated surgery, enhanced focus on surgical precision and outcomes.
The growing preference for minimally invasive technology is expected to support the expansion of the robotic surgery devices market in the coming years. Minimally invasive technology involves surgical procedures performed through small incisions using advanced instruments and robotic systems, which help limit tissue trauma and shorten recovery periods. This increasing preference is driven by patient demand for quicker recovery, fewer post-operative complications, and reduced hospital stays. As a result, adoption of robotic-assisted platforms is accelerating, as these systems enhance surgical precision, enable complex interventions, and improve overall clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, minimally invasive procedures grew by 7 percent in 2023, exceeding the growth rate of surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid fillers surpassing 9 million and 5 million treatments, respectively. Consequently, the increasing demand for minimally invasive technology is contributing significantly to the growth of the robotic surgery devices market.
Leading companies operating in the robotic surgery devices market are increasingly emphasizing technological innovation, particularly through the development of advanced robotic surgery platforms, to improve procedural efficiency, surgical accuracy, and overall economic performance. These platforms are being engineered to minimize radiation exposure, enhance surgeon ergonomics, and support faster patient recovery through minimally invasive approaches. R-One+ is a robotic system designed for cardiac procedures. For example, in May 2023, Robocath, a France-based medical technology company, launched R-One+, a new robotic system for heart surgery. The R-One+ platform is designed to enhance treatment precision and safety, reduce radiation exposure, and improve the overall patient experience. By enabling interventional cardiologists to perform coronary angioplasty procedures using a tablet and joystick interface, this system represents a notable advancement in interventional cardiology, offering clinicians a tool to improve patient outcomes while lowering procedural risks.
In October 2025, Zimmer Biomet Holdings, Inc., a United States-based medical technology company, completed the acquisition of Monogram Technologies, Inc. for an undisclosed consideration. Through this transaction, Zimmer Biomet seeks to strengthen its position in the robotic surgery devices market by integrating Monogram’s semi-autonomous and fully autonomous robotic systems into its existing portfolio. This includes incorporating Monogram’s computed tomography-based, artificial intelligence-navigated total knee arthroplasty technology into Zimmer Biomet’s robotic and navigation platforms. Monogram Technologies develops surgeon-guided robotic technologies for orthopedic applications, with a particular focus on total knee arthroplasty, and the acquisition is expected to enhance Zimmer Biomet’s capabilities in autonomous orthopedic robotics.
Major companies operating in the robotic surgery devices market are Intuitive Surgical Inc., Stryker Corporation, Medtronic plc, Smith & Nephew plc, Johnson & Johnson, TransEnterix Inc., Zimmer Biomet Holdings Inc., Auris Health Inc., CMR Surgical Ltd., Verb Surgical Inc., Renishaw plc, Think Surgical Inc., Corindus Vascular Robotics Inc., Mazor Robotics Ltd., Titan Medical Inc., Virtual Incision Corporation, Medrobotics Corporation, Preceyes BV, Microbot Medical Inc., Asensus Surgical Inc., Avatera Medical GmbH, Medicaroid Corporation, Hansen Medical Inc., Edge Surgical Inc., Synaptive Medical, Aesculap Inc.
North America was the largest region in the robotic surgery devices market in 2025. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the robotic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the robotic surgery devices market by increasing costs of imported robotic arms, sensors, vision systems, electronic control units, and precision instruments. Hospitals in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces manufacturing and export cost pressures. These tariffs are increasing system acquisition costs and slowing new installations. However, they are also encouraging localized assembly, regional component sourcing, and innovation in modular robotic surgery systems.
The robotic surgery devices market research report is one of a series of new reports that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robotic surgery devices play a crucial role in enabling doctors to execute intricate minimally invasive procedures with precision and adaptability.
The primary offerings within the robotic surgery devices market include robotic systems, instruments and accessories, as well as services. The services, also known as robot-assisted surgery services, are delivered by the robotic systems. These devices find application in various surgical categories such as urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These advanced tools are utilized in both hospital settings and ambulatory surgery centers.
Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Robotic Surgery Devices Market Characteristics
3. Robotic Surgery Devices Market Supply Chain Analysis
4. Global Robotic Surgery Devices Market Trends and Strategies
5. Robotic Surgery Devices Market Analysis of End Use Industries
7. Global Robotic Surgery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Robotic Surgery Devices Total Addressable Market (TAM) Analysis for the Market
9. Robotic Surgery Devices Market Segmentation
10. Robotic Surgery Devices Market Regional and Country Analysis
11. Asia-Pacific Robotic Surgery Devices Market
12. China Robotic Surgery Devices Market
13. India Robotic Surgery Devices Market
14. Japan Robotic Surgery Devices Market
15. Australia Robotic Surgery Devices Market
16. Indonesia Robotic Surgery Devices Market
17. South Korea Robotic Surgery Devices Market
18. Taiwan Robotic Surgery Devices Market
19. South East Asia Robotic Surgery Devices Market
20. Western Europe Robotic Surgery Devices Market
21. UK Robotic Surgery Devices Market
22. Germany Robotic Surgery Devices Market
23. France Robotic Surgery Devices Market
24. Italy Robotic Surgery Devices Market
25. Spain Robotic Surgery Devices Market
26. Eastern Europe Robotic Surgery Devices Market
27. Russia Robotic Surgery Devices Market
28. North America Robotic Surgery Devices Market
29. USA Robotic Surgery Devices Market
30. Canada Robotic Surgery Devices Market
31. South America Robotic Surgery Devices Market
32. Brazil Robotic Surgery Devices Market
33. Middle East Robotic Surgery Devices Market
34. Africa Robotic Surgery Devices Market
36. Robotic Surgery Devices Market Competitive Landscape and Company Profiles
37. Robotic Surgery Devices Market Other Major and Innovative Companies
40. Robotic Surgery Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Robotic Surgery Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses robotic surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for robotic surgery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic surgery devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Robotic systems; Instruments & Accessories; Services2) By Application: General Surgery; Urological Surgery; Gynecological Surgery; Orthopaedics Surgery; Neurosurgery; Other Applications.
3) By End-Use: Hospitals; Ambulatory Surgery Centers (Ascs)
Subsegments:
1) By Robotic Systems: Surgical Robotic Systems; Teleoperated Robotic Systems; Autonomous Robotic Systems2) By Instruments And Accessories: Surgical Instruments; Endoscopes; Vision Systems; Energy Devices
3) By Services: Maintenance And Repair Services; Training And Support Services; Consulting Services
Companies Mentioned: Intuitive Surgical Inc.; Stryker Corporation; Medtronic plc; Smith & Nephew plc; Johnson & Johnson; TransEnterix Inc.; Zimmer Biomet Holdings Inc.; Auris Health Inc.; CMR Surgical Ltd.; Verb Surgical Inc.; Renishaw plc; Think Surgical Inc.; Corindus Vascular Robotics Inc.; Mazor Robotics Ltd.; Titan Medical Inc.; Virtual Incision Corporation; Medrobotics Corporation; Preceyes BV; Microbot Medical Inc.; Asensus Surgical Inc.; Avatera Medical GmbH; Medicaroid Corporation; Hansen Medical Inc.; Edge Surgical Inc.; Synaptive Medical; Aesculap Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Robotic Surgery Devices market report include:- Intuitive Surgical Inc.
- Stryker Corporation
- Medtronic plc
- Smith & Nephew plc
- Johnson & Johnson
- TransEnterix Inc.
- Zimmer Biomet Holdings Inc.
- Auris Health Inc.
- CMR Surgical Ltd.
- Verb Surgical Inc.
- Renishaw plc
- Think Surgical Inc.
- Corindus Vascular Robotics Inc.
- Mazor Robotics Ltd.
- Titan Medical Inc.
- Virtual Incision Corporation
- Medrobotics Corporation
- Preceyes BV
- Microbot Medical Inc.
- Asensus Surgical Inc.
- Avatera Medical GmbH
- Medicaroid Corporation
- Hansen Medical Inc.
- Edge Surgical Inc.
- Synaptive Medical
- Aesculap Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.19 Billion |
| Forecasted Market Value ( USD | $ 18.08 Billion |
| Compound Annual Growth Rate | 15.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
